Skip to main content
  • Home
  •  Available Courses

Most Recent Courses

Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice
  • 1.00 EBAC

Learning objectives

  • Identify patient populations who may benefit from hybrid ablation
  • Summarise the existing rationale and evidence for hybrid ablation beyond atrial fibrillation
  • Understand how to integrate left atrial appendage exclusion in atrial ablation approaches
  • Examine key aspects of new consensus recommendations for hybrid ablation
See more
TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
  • 1.00 EBAC

Learning objectives

  • Recall TAVI SMART trial data and the implications on clinical practice
  • Describe novel valve designs and the impact on long-term performance
  • Develop an expert-led approach to improving equitable access to TAVI
See more
TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
  • 1.00 EBAC

Learning objectives

  • Evaluate the factors influencing coronary access in different valve designs
  • Formulate strategies to optimise coronary access based on valve characteristics
  • Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
  • Learn the step-by-step process for achieving optimum implant depth during TAVI
  • Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
See more
Getting it Right First Time in Severe Aortic Stenosis - Key Insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Elevating Understanding and Management of Hypertriglyceridemia
  • 1.25 AMA PRA Credit

Learning objectives

  • Understand HTG as a risk factor for acute and chronic illness
  • Describe current guideline directed management of HTG
  • Recognise the gaps and challenges present in current guideline directed management of HTG
  • Recall emerging trial data for novel pharmacological targets
  • Use guidelines, trial data & expert opinion to develop individualised treatment strategies for high-risk patients
See more
Implementing Heart Failure Guidelines with Collaborative Care
  • Not accredited

Learning objectives

  • Appraise new updates in heart failure guideline-directed medical therapy (GDMT)
  • Apply latest guideline recommendations to patient cases
  • Describe barriers preventing early initiation of GDMT
  • Identify the roles of nurses and other healthcare professionals to achieve optimal heart failure therapy
  • Identify the importance of the nurse/cross-functional team
See more
The Advancing Management of Transthyretin Amyloidosis
  • 1.00 EBAC

Learning objectives

  • To differentiate ATTR phenotypes based on presenting signs and symptoms.
  • To select appropriate tests to monitor symptomatic ATTR-cm from imaging, biomarker, functional and QoL assessments.
  • To recall how to identify disease progression across ATTR-cm.
  • To describe the different disease modifying treatments for ATTR including novel agents.
See more
An Expert Interpretation of the ESC Cardiomyopathy Guidelines 2023
  • 1.00 EBAC

Learning objectives

  • Recall guideline updates relevant to the use of disease modifying agents in hypertrophic cardiomyopathy
  • Identify patients who, according to guidelines, may benefit from emerging disease modifying therapies prior to septal ablation therapy or being managed by symptom control alone
  • Discuss long-term management strategies for patients receiving myosin inhibitor therapy
See more
Achieving Lipid Targets & Managing CV Risk: Reassessing our way with Statins
  • 1.00 EBAC

Learning objectives

  • Recall prevalence of patients who are statin uncontrolled/intolerant
  • Define the additive benefit of combination treatment compared with statin intensification
  • Name the non-statin LLTs offering proven CV protection
  • Identifying patients with indication for novel non-statin therapy
  • Initiate lipid-lowering strategies proven to lower future CV events
See more